Insider Transactions in Q3 2023 at Tff Pharmaceuticals, Inc. (TFFP)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 16
2023
|
Carlson Capital L P > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,000
-0.02%
|
$0
$0.39 P/Share
|
|
Aug 15
2023
|
Carlson Capital L P > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
215,000
-4.07%
|
$0
$0.44 P/Share
|
|
Aug 15
2023
|
Zamaneh Mikhak Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
120,000
+47.06%
|
$0
$0.25 P/Share
|
|
Aug 15
2023
|
Robert S Mills Director |
BUY
Open market or private purchase
|
Direct |
40,000
+41.68%
|
$0
$0.25 P/Share
|
|
Aug 15
2023
|
Kirk Allen Coleman Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+35.92%
|
$0
$0.25 P/Share
|
|
Aug 15
2023
|
Brandi Roberts Director |
BUY
Open market or private purchase
|
Direct |
20,000
+50.0%
|
$0
$0.25 P/Share
|
|
Aug 15
2023
|
Stephen Rocamboli Director |
BUY
Open market or private purchase
|
Direct |
20,000
+35.71%
|
$0
$0.25 P/Share
|
|
Aug 15
2023
|
Harlan F Weisman President and CEO |
BUY
Open market or private purchase
|
Direct |
600,000
+42.41%
|
$0
$0.25 P/Share
|